Vancomycin-resistant Gram-positive cocci: Risk factors for faecal carriage

Journal of Hospital Infection

Volumn 35, Issue 1, 1997, Pages 63-69

  Gopal Rao, G ^a   Ojo, F ^a   Kolokithas, D ^a  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

Risk factors; Vancomycin resistant Gram positive cocci

Indexed keywords

CEPHALOSPORIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTERY CATHETERIZATION; ARTICLE; BACTERIUM CARRIER; CASE CONTROL STUDY; CENTRAL VENOUS CATHETERIZATION; CLINICAL ARTICLE; ENTEROCOCCUS; FECES; GRAM POSITIVE COCCI; HOSPITALIZATION; HUMAN; INFECTION CONTROL; LENGTH OF STAY; ORAL DRUG ADMINISTRATION; RISK FACTOR;

EID: 12644282515     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(97)90169-9     Document Type: Article

References (18)

1. Woodford N, Johnson AP, Morrison D, Speller DCE. Current perspectives on glycopeptode resistance. Clin Microbiol Rev 1995; 8: 585-615.
2. Spera RV Jr, Farber BF. Multiply-resistant Enterococcus faecium: the nosocomial pathogen of the 1990s. JAMA 1992; 268: 2563-2564.
3. The Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance: Am J Infect Control 1995; 23: 87-94.
4. CDR weekly. Vancomycin resistant enterococci in hospitals in the United Kingdom. Commun Dis Rep CDR Weekly 1995; 5: 50: 281.
5. Noble WC, Virani Z, Cree R. Co transfer for vancomycin and other resistance genes from Enterococcus faecalis; NCTC 12202 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-198.
6. Dukta-Malen S, Blaimont B, Wauters G, Courvalin P. Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother 1994; 38: 1675-1677.
7. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP. Vancomycin-resistant Enterococcus faecium Bacteraemia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-1133.
8. Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiological study. Am J Infect Control 1995; 23: 170-180.
9. Gopal Rao G, Morris KJ, George RC, Woodford N. Vancomycin-resistant enterococci in a district general hospital. Lancet 1992; 340: 1471-1472.
10. Green M, Barbadora K, Michaels M. Recovery of vancomycin resistant Gram-positive cocci from paediatric liver transplant patients. J Clin Microbiol 1991; 29: 2503-2506.
11. Livornese LL, Dias S, Samel C, Romanowski B, Taylor S, May P, Pitsakis P, Woods G, Kay D Livison ME, Johnson CC. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117: 112-116.
12. Gopal Rao G, Ghanekar K, Ojo F. Selective medium for screening for vancomycin-resistant enterococci in faeces. Eur J Clin Microbiol Infect Dis 1996; 15: 175-177.
13. Department of Health and Public Health Laboratory Service. Report of joint working group. Clostridium difficile infection. Prevention and Management 1994; 7-10.
14. Swenson JM, Ferraro MJ, Sahm DF, Doern G, Pfaller MA, Reller LB, Weinstein MP, Zabaransky RJ, Tenover FC. Development of standardised screening method for vancomycin resistant enterococci. J Clin Microbiol 1994; 32: 1700-1704.
15. Colledge CL. Infection due to Leuconostoc species. Rev Infect Dis 1991; 13: 184-185.
16. Ruoff KL, de la Maza L, Murtagh MJ et al. Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 1990; 28: 435-437.
17. French GY, Abdulla Y, Heathcock R, Poston S, Cameron J. Vancomycin resistance in South London. Lancet 1992; 339: 818-819.
18. Power EGM, Abdulla YH, Talsania HG, Spice W, Aathithan S, French GL. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother 1995; 36: 595-606.